| 000 | 01283 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512195213.0 | ||
| 264 | 0 | _c19810526 | |
| 008 | 198105s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBylund, D B | |
| 245 | 0 | 0 |
_aInteractions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cApr 1981 |
||
| 300 |
_a81-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xmetabolism |
| 650 | 0 | 4 |
_aDioxanes _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aQuinuclidinyl Benzilate _xmetabolism |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 |
_aReceptors, Adrenergic _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Cholinergic _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Muscarinic _xmetabolism |
| 650 | 0 | 4 | _aSheep |
| 650 | 0 | 4 |
_aSpiperone _xmetabolism |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 217 _gno. 1 _gp. 81-6 |
|
| 999 |
_c6110867 _d6110867 |
||